Circulating nucleic acids in cancer and pregnancy (Q37690454)

22 August 2017

1 reference

title

Circulating nucleic acids in cancer and pregnancy (English)

1 reference

22 August 2017

Francesca Salvianti

2

0 references

Mario Pazzagli

object named as

Mario Pazzagli

series ordinal

3

0 references

author name string

Pamela Pinzani

series ordinal

1

1 reference

PubMed ID

20146940

22 August 2017

Claudio Orlando

series ordinal

4

1 reference

22 August 2017

8 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

50

1 reference

22 August 2017

4

1 reference

22 August 2017

302-307

1 reference

Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulation DNA: biological implications for cancer metastasis and immunology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of circulating fetal nucleic acids: a review of methods and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Rapid clearance of fetal DNA from maternal plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Fate of Injected Deoxyribonucleic Acid in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

A method for characterization of total circulating DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Profile of the circulating DNA in apparently healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Characterisation of circulating DNA by parallel tagged sequencing on the 454 platform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection and quantification of mutations in the plasma of patients with colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Functionality of circulating DNA: the hypothesis of genometastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Genomic tests: unreliable for cancer? A focus on circulating DNA and lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Changes in Concentration of DNA in Serum and Plasma during Storage of Blood Samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Effects of blood-processing protocols on cell-free DNA quantification in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Down syndrome and cell-free fetal DNA in archived maternal serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Optimization of purification of human cell-free mRNA from plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating DNA. Its origin and fluctuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Isolation and characterization of DNA from the plasma of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Free DNA in serum and plasma from normal adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantification of circulating DNA in the plasma and serum of cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantification of free circulating DNA as a diagnostic marker in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

First-trimester maternal plasma cell-free fetal DNA and preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Characterization of circulating DNA in healthy human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Size distributions of maternal and fetal DNA in maternal plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Increased plasma DNA integrity index in head and neck cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

DNA integrity in plasma and serum of patients with malignant and benign diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating DNA: a new diagnostic gold mine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Mutations in K-ras Codon 12 Detected in Plasma DNA Are Not an Indicator of Disease in Patients with Non-Small Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Quantitative detection of p53 mutations in plasma DNA from tobacco smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

The detection of oesophageal adenocarcinoma by serum microsatellite analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating nucleic acids in plasma/serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

mRNA of placental origin is readily detectable in maternal plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating placental RNA in maternal plasma is associated with a preponderance of 5' mRNA fragments: implications for noninvasive prenatal diagnosis and monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Digital PCR for the molecular detection of fetal chromosomal aneuploidy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Coamplification at lower denaturation temperature-PCR increases mutation-detection selectivity of TaqMan-based real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Characterizing peptide-mediated DNA internalization in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Paramutation: from maize to mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Exosome function: from tumor immunology to pathogen biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

Detection of amplifiable messenger RNA in the serum of patients with lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2010.02.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2010.02.004

1 reference

22 August 2017

1 reference

PubMed ID

20146940